You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2024

Claims for Patent: 10,851,118


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,851,118
Title:Compositions and methods for inhibiting arginase activity
Abstract:The invention relates to a novel class of compounds that exhibit activity inhibitory activity toward arginase, and pharmaceutical compositions comprising the compounds of the invention. Also provided herein are methods of treating cancer with the arginase inhibitors of the invention.
Inventor(s):Sjogren Eric B., Li Jim, Van Zandt Michael, Whitehouse Darren
Assignee:CALITHERA BIOSCIENCES, INC.
Application Number:US16101275
Patent Claims:

Details for Patent 10,851,118

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Recordati Rare Diseases, Inc. ELSPAR asparaginase For Injection 101063 January 10, 1978 10,851,118 2038-08-10
Amgen Inc. NEUPOGEN filgrastim Injection 103353 February 20, 1991 10,851,118 2038-08-10
Amgen Inc. NEUPOGEN filgrastim Injection 103353 June 28, 2000 10,851,118 2038-08-10
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 May 07, 2001 10,851,118 2038-08-10
Genzyme Corporation LEMTRADA alemtuzumab Injection 103948 November 14, 2014 10,851,118 2038-08-10
Genzyme Corporation CAMPATH alemtuzumab Injection 103948 October 12, 2004 10,851,118 2038-08-10
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.